Want to see BDMD full AI Analyst Report?
BDMD Stock Chart & Stats
$1.76
$0.13(1.73%)
At close: 4:00 PM EST
$1.76
$0.13(1.73%)
Day’s Range― - ―
52-Week Range$0.76 - $3.75
Previous Close$7.55
Volume323.07K
Average Volume (3M)238.60K
Market Cap
$49.81M
Enterprise Value$66.66M
Total Cash (Recent Filing)$178.32K
Total Debt (Recent Filing)$19.30M
Price to Earnings (P/E)―
Beta-0.65
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding42,208,763
10 Day Avg. Volume117,298
30 Day Avg. Volume238,602
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.21
Price to Sales (P/S)1.68
P/FCF Ratio-27.26
Enterprise Value/Market Cap1.34
Enterprise Value/Revenue2.96
Enterprise Value/Gross Profit3.53
Enterprise Value/Ebitda-2.75
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Manageable Leverage / Equity CushionDebt roughly 0.62x equity provides a meaningful capital cushion and financial flexibility versus highly leveraged peers. Over the next several months this cushion can absorb near-term volatility and buy time for operational fixes, preserving optionality for refinancing or restructuring if losses persist.
High Gross MarginsSustained very high gross margins point to favorable product economics and potential pricing power typical of differentiated medical-device offerings. If management controls SG&A and R&D spend, these margins support profitable recovery and durable competitive advantage in core products over a multi-month horizon.
Lean HeadcountA relatively small workforce suggests a lean cost structure and potential for scalable fixed-cost leverage. This can help preserve cash burn and allow faster operational adjustments, which is advantageous while the company stabilizes revenues and rebalances investments in R&D or commercialization.
Bears Say
Sharp Revenue DeteriorationA near-30% revenue decline indicates durable demand weakness, pricing pressure, or lost market share rather than a transitory blip. Such a revenue contraction materially reduces operating leverage benefits, complicates margin recovery, and limits the company's ability to invest in growth or absorb fixed costs in the coming quarters.
Chronic Negative Cash GenerationPersistent negative operating and free cash flow across multiple years undermines internal funding capacity and forces reliance on external capital or asset sales. Over a medium-term horizon this raises dilution or refinancing risk, constrains strategic initiatives, and limits the company’s ability to self-fund recovery or regulatory/commercial milestones.
Swing To Deep Losses And Negative ROEA rapid swing from profit to significant losses signals structural earnings volatility, potential one-off charges, or persistent margin deterioration. Negative ROE erodes shareholder equity and undermines reinvestment capacity, making multi-month operational recovery harder without clear corrective actions or capital support.
Baird Medical Investment Holdings News
BDMD FAQ
What was Baird Medical Investment Holdings’s price range in the past 12 months?
Baird Medical Investment Holdings lowest stock price was $0.76 and its highest was $3.75 in the past 12 months.
What is Baird Medical Investment Holdings’s market cap?
Baird Medical Investment Holdings’s market cap is $49.81M.
When is Baird Medical Investment Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Baird Medical Investment Holdings’s earnings last quarter?
Currently, no data Available
Is Baird Medical Investment Holdings overvalued?
According to Wall Street analysts Baird Medical Investment Holdings’s price is currently Overvalued.
Does Baird Medical Investment Holdings pay dividends?
Baird Medical Investment Holdings does not currently pay dividends.
What is Baird Medical Investment Holdings’s EPS estimate?
Baird Medical Investment Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Baird Medical Investment Holdings have?
Baird Medical Investment Holdings has 42,208,763 shares outstanding.
What happened to Baird Medical Investment Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Baird Medical Investment Holdings?
Currently, no hedge funds are holding shares in BDMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Baird Medical Investment Holdings Stock Smart Score
Company Description
Baird Medical Investment Holdings
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.
Technical Analysis
Ownership Overview
―
Insiders
0.06% Mutual Funds
0.59% Other Institutional Investors
99.35% Public Companies and
Individual Investors